Tenaya therapeutics to participate at the 21st annual morgan stanley global healthcare conference

South san francisco, calif., aug. 31, 2023 (globe newswire) -- tenaya therapeutics, inc. (nasdaq: tnya), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that faraz ali, chief executive officer, will participate in the 21st annual morgan stanley global healthcare conference taking place in new york city. details of participation are as follows:
TNYA Ratings Summary
TNYA Quant Ranking